Multi-center clinical study of Parkon® efficiency
<p>The purpose of the study was to investigate the efficacy of Parkon® spray as the compound for the effect on motor disturbances in treatment of both Parkinson's Disease (PD) and neuroleptic-induced Parkinsonism. The main active ingredient of Parkon® is low concentrated hydrogen peroxide...
Wedi'i Gadw mewn:
Prif Awduron: | Fjodorova NE (Awdur), Shtok VH (Awdur), Gusev EI (Awdur), Naum Goldstein (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Open Journal of Parkinson's Disease and Treatment - Peertechz Publications,
2021-10-29.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Parkon® in the treatment of multiple sclerosis. A pilot study
gan: Goldstein NI, et al.
Cyhoeddwyd: (2020) -
Parkon as a treatment of the Parkinson's disease
gan: Golubev VL, et al.
Cyhoeddwyd: (2019) -
The results of a clinical and neurophysiological study of the effectiveness of Parkon spray in the treatment of Parkinson's Disease (PD)
gan: Gekht BM, et al.
Cyhoeddwyd: (2022) -
How does medicine Parkon® affect the MPTP-induced oxidation stress and MAO systems of the rats brain
gan: N Goldstein, et al.
Cyhoeddwyd: (2021) -
Current knowledge on the neuroprotective and neuroregenerative properties of citicoline in acute ischemic stroke
gan: Martynov MY, et al.
Cyhoeddwyd: (2015)